61
Views
6
CrossRef citations to date
0
Altmetric
Drug Profile

Treatment of type I and II hereditary angioedema with Rhucin®, a recombinant human C1 inhibitor

&
Pages 653-661 | Published online: 10 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Roberto Castelli, Andrea Zanichelli & Massimo Cugno. (2013) Therapeutic options for patients with angioedema due to C1-inhibitor deficiencies: from pathophysiology to the clinic. Immunopharmacology and Immunotoxicology 35:1, pages 181-190.
Read now
Lilian Varga & Henriette Farkas. (2011) rhC1INH: a new drug for the treatment of attacks in hereditary angioedema caused by C1-inhibitor deficiency. Expert Review of Clinical Immunology 7:2, pages 143-153.
Read now

Articles from other publishers (4)

Davide Firinu, Pier P. Bassareo, Angela M. Zedda, Maria P. Barca, Antonio Crisafulli, Giuseppe Mercuro & Stefano Del Giacco. (2018) Impaired Endothelial Function in Hereditary Angioedema During the Symptom-Free Period. Frontiers in Physiology 9.
Crossref
Jan Over, Christine Kramer, Anky Koenderman, Diana Wouters & Sacha Zeerleder. 2013. Production of Plasma Proteins for Therapeutic Use. Production of Plasma Proteins for Therapeutic Use 241 258 .
Marco CicardiHenriette FarkasLilian Varga. 2012. Current and Emerging Options for Hereditary Angioedema Management. Current and Emerging Options for Hereditary Angioedema Management 32 45 .
Timothy Craig, Emel Aygören Pürsün, Konrad Bork, Tom Bowen, Henrik Boysen, Henriette Farkas, Anete Grumach, Constance H. Katelaris, Richard Lockey, Hilary Longhurst, William Lumry, Markus Magerl, Immaculada Martinez-Saguer, Bruce Ritchie, Alexander Nast, Ruby Pawankar, Bruce Zuraw & Marcus Maurer. (2012) WAO Guideline for the Management of Hereditary Angioedema. World Allergy Organization Journal 5:12, pages 182-199.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.